Its a no-brainer today to talk about the need for bridging Information Technology (IT) with the pharmaceutical business. We all know that both business and IT stakeholders understand this extremely well. Everyone recognizes the value, but pharmaceutical companies are often still reluctant to commit fully to an IT initiative. Why is this the case?
The skepticism stems from concerns about delivering the right solution to address the business issues and needs at the right time, and not after the event is over. If IT needs to build a solution to improve product launch effectiveness, the solution has to be delivered before launching the campaign, and not after the brand team has exerted all of its energy into the campaign.
The key challenge is to make IT an integral part of the business operations. If Quality Assurance/Quality Control (QA/QC), engineering maintenance and raw materials management teams can become part of the core pharmaceutical manufacturing function, why not IT as well? Why is IT seen as an outsider?
The traditional tendency to treat IT as support to business reduces its potential to become a part of business and to deliver much more. The Booz Allen Hamilton and CIO survey1 showed that in an organization where CIOs are part of the CEOs core team, IT showed healthier outputs than where they werent. Why, then, are CIOs not reporting to CEOs in every organization? The biggest reason is ITs inability to improve business operations and deliver value on time. Also, IT often fails to remain aligned with the pace of ever-changing business, as it has been more focused on managing todays tasks and not focused on future potential. IT must align itself closer to the business and demonstrate how technology-driven innovation can help businesses excel.
Businesses often believe that IT teams are too focused on their job-at-hand and less on becoming a true business transformation partner that proactively thinks about technology-driven business improvement. The typical IT project requires businesses to provide the requirements and accept whatever solutions are delivered in the end. This approach leads to only about 30%2 success in project delivery.
What is the reason for such a high failure rate? From an IT point of view, the number one reason is not getting enough business time during the project. This is not specific to any project or business unit, but its the cultural construct in an organization that drives this business-IT work dynamic. Typically, businesses ask for technology help and then the IT team creates the solutions and asks business to accept them but this seldom produces the best results.
So, business and IT need a much closer working relationship. The collaboration process should not happen only when a project is being designed, but as an acceptable, regular practice to create a business-IT knowledge foundation that can be used in all projects. This knowledge foundation can make projects successful even with a minimum amount of business time invested. This encourages stakeholders to make IT a core business support function. This foundation can be created if business gets to know the solutions better and accepts accountability for project success. Unless IT collaborates with the business and shares knowledge to make all stakeholders understand the solution, the issues will remain. Currently, the industry is far from adopting this culture and many business-oriented IT projects do not see enough business participation. This situation must be resolved, and this can be done only with improved knowledge sharing between business and IT.
There are a few potentially tricky situations that make businesses nervous about adopting IT solutions:
Use of standard products:
The making of custom-built systems:
Dilemma between niche apps and the enterprise
All of these factors contribute to making businesses unhappy. But the level of unhappiness is not weighty enough to jeopardize the majority of the projects. What actually reduces business involvement are the cultural differences between the functions. Both business and IT need to work toward creating a work culture that is more collaborative. This can be enhanced by showcasing the values every stakeholder contributes to making a project successful. This further supports the idea that IT functions need to be presented well and the business benefits outlined accordingly, so that neither function can overlook its necessity.
Businesses need to become more comfortable engaging with their IT operations and IT has to go beyond the tactical day-to-day operational mode in supporting business changes. This is possible only when both teams have a good understanding of each others needs.
When I managed a pharmaceutical manufacturing plant, I hardly paid any attention to the IT initiatives - it was the least important task on my agenda. Now, I realize how wrong I was. My change in approach is a result of simply paying more attention to technology-driven innovation and greater knowledge, on my part, of how IT can deliver business values. With this improved knowledge, I now strongly advocate the need to link IT with business for improved business operation.
Both business and IT understand that many of the factors that make businesses unhappy are external to the pharmaceutical organization, e.g. product companies. With new work cultures, both business and IT will be able to successfully deal with external factors. This helps in better customization of standard products, developing a system that exactly matches business needs and working together to deal with other technology barriers. Creation of high level educational material, use of timely communication techniques, regular knowledge sharing sessions during breakfast or lunch and creating IT awareness campaigns could help build stronger bonds between IT and business.
A value-based approach from the IT team can change the face of IT in the eyes of business. Pharmaceutical organizations can gain much more value from their IT teams, just like many other industries. All the necessary materials exist to build a strong bridge between IT and business, organizations need only decide that today is the day to begin this journey!
About the author:
Kamal Biswas is a Senior Principal with the Life Sciences Practice at Infosys Consulting, Inc. Kamal is an expert in pharmaceutical manufacturing & technology strategy and regulatory compliance in FDA regulated industries. He has more than 15 years experience in pharmaceutical manufacturing operations and business consulting. He is a thought leader in pharma IT strategy, technology enabled productivity in pharmaceutical manufacturing operation, and regulatory compliance transformation. Kamal lives in New Jersey, USA, and can be reached at kamal_biswas@infosys.com.
blog comments powered by Disqus
Andrew Tolve investigates the value of the Internet as a pharma marketing research medium
Often criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
Jan Stojaspal explores the role of value-based pricing in gaining market access
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs